Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CRBP is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
23 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 29 days ago
Red flags: 0
107 filers reported a long position in CRBP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Cormorant Asset Management, LP | $22M | 2.3M | Unchanged |
| ORBIMED ADVISORS LLC | $16.3M | 1.7M | Unchanged |
| BlackRock, Inc. | $12.5M | 1.3M | +390% |
| Aberdeen Group plc | $12.4M | 1.3M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.1M | 760.9K | +3.7% |
| Jones Hill Capital LP | $6.1M | 653.6K | New |
| Prosight Management, LP | $6.1M | 650K | -6.8% |
| Stonepine Capital Management, LLC | $4M | 425K | +10.8% |
| GEODE CAPITAL MANAGEMENT, LLC | $4M | 423.4K | +126.4% |
| ADAR1 Capital Management, LLC | $4M | 421.8K | +27.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.